Glabrene exhibits multiple pharmacological activities, including superoxide anion scavenging, tyrosinase inhibition (IC50 = 3.5 μM), and estrogen-like effects; it also demonstrates anti-proliferative effects on HepaRG and Caco-2 cells, potentially through induction of apoptosis and G2/M cell cycle arrest.